TrialJapanese journal of clinical oncology2023

Liposomal irinotecan with fluorouracil and leucovorin after gemcitabine-based therapy in Japanese patients with metastatic pancreatic cancer: additional safety analysis of a randomized phase 2 trial.

Junji Furuse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.